Home › Degenerative Nerve Diseases › NCT05443906
Home Exercise for Individuals With Neurodegenerative Disease
RecruitingHealthy volunteers welcome
Study of Adapted Exercise and Mindfulness Interventions to Improve Motor Function and Sleep Quality in Individuals With Neurodegenerative Disease
Who can join
Ages 5 to 75 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * The eligibility criteria for males is X-linked adrenoleukodystrophy as determined by biochemical determination or genetic testing. * The eligibility criteria for females is X-linked adrenoleukodystrophy as determined by biochemical determination, genetic testing, or pedigree analysis. * The Leukoenceophalopathy with brainstem and spinal cord involvement and lactate elevation inclusion criterion is a confirmed DARS2 mutation through genetic analysis. * For people with cerebellar ataxia, people with diagnoses of cerebellar damage from stroke, tumor or degeneration will be included. Those with a genetically confirmed cerebellar disorder will be asked to provide their genetic testing to note their particular type of ataxia. * We will also include patients with other neurodegenerative diseases similar to these disorders as determined by chart review and clinical exam. Healthy Volunteers * Able to stand for 30 seconds without upper extremity support * Ambulatory (including use of a cane or a walker) * Able to walk for 2 minutes Exclusion Criteria: * Other medical or psychological conditions which in the clinical judgement of the investigator would interfere with acquiring the study information or performing the exercises safely including but not limited to: Uncontrolled hypertension, orthopedic conditions, diabetes, seizure disorder, peripheral vestibular loss, severe aphasia, dementia, pregnancy
About the study
The primary goal of this study is to address the need for targeted therapeutic interventions for impairments that impact walking in related neurodegenerative diseases.
What is being tested
- Home exercise (behavioral)
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · Participants: 30 · Started: Feb 13, 2023
Contact the study team
- Jennifer L Keller, PT, MS · Phone: 443-923-2716
- Amena Smith Fine, MD PhD · Phone: 443-923-3249
Official record on ClinicalTrials.gov — NCT05443906
Locations in the U.S.
| Maryland | Kennedy Krieger Institute, Baltimore |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.